Gonadotropin-releasing hormone peptide (diagnostic and fertility use)
GnRH
The native GnRH decapeptide used diagnostically and therapeutically to stimulate LH/FSH for fertility and hormonal assessment.
- Evidence:
- Strong human evidence
- Status:
- FDA-approved for specific labeled indications
- Reviewed:
- 2026-08-03
Also known as: GnRH, LHRH, Factrel
What is GnRH?
The native GnRH decapeptide used diagnostically and therapeutically to stimulate LH/FSH for fertility and hormonal assessment.
This profile is educational. It organizes publicly discussed research context for GnRH and related naming aliases — it is not a treatment guide.
Proposed mechanism
Pulsatile GnRH receptor activation on pituitary gonadotrophs stimulates LH and FSH release.
Mechanism language on PepGuide describes how researchers discuss pathways. Proposed mechanisms can change as evidence evolves.
Current research notes
Human evidence grade: Strong human evidence
Preclinical evidence grade: Strong human evidence
Gonadorelin (native GnRH) differs from long-acting GnRH agonists that cause downregulation. Used in fertility and diagnostic testing. Human evidence is established for approved uses. Also discussed in male fertility and hormonal research contexts (educational only).
Key uncertainties
- Pulsatile delivery optimization in research models
Research areas being studied
- Fertility
- Delayed puberty
- Diagnostic endocrinology
Being studied for a topic is not the same as proven benefit in that topic. Prefer primary literature for study design, endpoints, and limitations.
Safety & side-effect notes
Reported or discussed adverse effects
- Headache
- Abdominal discomfort
- Injection-site reactions
Additional risks & considerations
- Hormonal fluctuations
- Ovarian hyperstimulation in fertility protocols
Regulatory status
FDA-approved for specific labeled indications
FDA approved for diagnostic and fertility-related uses.
Regulatory framing here is educational and can lag policy changes. Check official sources for current status.
Frequently asked questions
What is GnRH?
The native GnRH decapeptide used diagnostically and therapeutically to stimulate LH/FSH for fertility and hormonal assessment.
How does GnRH work (proposed mechanism)?
Pulsatile GnRH receptor activation on pituitary gonadotrophs stimulates LH and FSH release.
What is GnRH being researched for?
GnRH has been discussed in research contexts including: Fertility, Delayed puberty, Diagnostic endocrinology.
What does current evidence say about GnRH?
Strong human evidence. Gonadorelin (native GnRH) differs from long-acting GnRH agonists that cause downregulation. Used in fertility and diagnostic testing. Human evidence is established for approved uses. Also discussed in male fertility and hormonal research contexts (educational only).
What safety considerations are noted for GnRH?
Reported or discussed considerations include: Headache; Abdominal discomfort; Injection-site reactions; Hormonal fluctuations; Ovarian hyperstimulation in fertility protocols. This is educational information, not medical advice.
Is GnRH FDA approved?
FDA-approved for specific labeled indications. FDA approved for diagnostic and fertility-related uses.
References & sources
- Conn PM (1994). GnRH and its analogs in reproductive medicine — Physiol Rev. Evidence type: review.
Prefer interactive tools? Open the PepGuide library entry for GnRH or ask PepGuide AI.
Educational and research information only. PepGuide does not sell or prescribe peptides, diagnose conditions, or provide personalized medical advice. Evidence summaries may include early-stage, animal, or limited human research — none of that is a substitute for primary literature or clinician guidance.